5/8
03:33 pm
nvct
Nuvectis Pharma, Inc. (NASDAQ: NVCT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
Low
Report
Nuvectis Pharma, Inc. (NASDAQ: NVCT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
5/7
08:14 am
nvct
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]
Medium
Report
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights [Yahoo! Finance]
5/7
08:00 am
nvct
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
Medium
Report
Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights
4/17
07:29 am
nvct
Is Nuvectis Pharma (NASDAQ:NVCT) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
High
Report
Is Nuvectis Pharma (NASDAQ:NVCT) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
4/8
08:49 am
nvct
Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines [Yahoo! Finance]
Low
Report
Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines [Yahoo! Finance]
4/8
08:30 am
nvct
Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines
Low
Report
Nuvectis Pharma's NXP900 Demonstrates Robust Activity in Non-Small Cell Lung Cancer Cell Lines
3/21
06:21 am
nvct
Insider Buys Additional US$51k In Nuvectis Pharma Stock [Yahoo! Finance]
Medium
Report
Insider Buys Additional US$51k In Nuvectis Pharma Stock [Yahoo! Finance]
3/19
08:13 am
nvct
Nuvectis Pharma Announces Upcoming Presentations at the 2024 American Association for Cancer Research Meeting [Yahoo! Finance]
High
Report
Nuvectis Pharma Announces Upcoming Presentations at the 2024 American Association for Cancer Research Meeting [Yahoo! Finance]
3/19
08:00 am
nvct
Nuvectis Pharma Announces Upcoming Presentations at the 2024 American Association for Cancer Research Meeting
High
Report
Nuvectis Pharma Announces Upcoming Presentations at the 2024 American Association for Cancer Research Meeting
3/15
08:00 am
nvct
Nuvectis Pharma to Present at the 36th Annual Roth Conference
High
Report
Nuvectis Pharma to Present at the 36th Annual Roth Conference
3/14
09:13 am
nvct
Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer [Yahoo! Finance]
High
Report
Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer [Yahoo! Finance]
3/14
09:00 am
nvct
Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer
Medium
Report
Nuvectis Pharma Announces Encouraging Preliminary Data from the NXP800 Phase 1b Clinical Trial in Platinum-Resistant ARID1a-Mutated Ovarian Cancer
3/5
08:50 am
nvct
Nuvectis Pharma Inc (NVCT) Reports Increased Net Loss in FY 2023 Despite Clinical Progress [Yahoo! Finance]
Medium
Report
Nuvectis Pharma Inc (NVCT) Reports Increased Net Loss in FY 2023 Despite Clinical Progress [Yahoo! Finance]
3/5
08:10 am
nvct
Nuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results and Business Highlights [Yahoo! Finance]
High
Report
Nuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results and Business Highlights [Yahoo! Finance]
3/5
08:00 am
nvct
Nuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results and Business Highlights
High
Report
Nuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results and Business Highlights
2/19
08:01 am
nvct
Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders have significant skin in the game with 67% ownership [Yahoo! Finance]
Medium
Report
Nuvectis Pharma, Inc. (NASDAQ:NVCT) insiders have significant skin in the game with 67% ownership [Yahoo! Finance]